Vannevar Labs stock
Private-market facts for current and former Vannevar Labs employees researching their stock.
Overview
Defense technology company building AI-powered tools for intelligence analysis and decision-making used by national security and defense agencies.
Selling Vannevar Labs shares
Why shareholders consider selling
Shareholders in Vannevar Labs may explore liquidity for a number of reasons — diversifying a concentrated position, funding a personal financial goal, or simply reducing exposure to a single private holding. As a private company, Vannevar Labs does not trade on a public exchange, meaning employees and early shareholders cannot simply sell through a brokerage. Extended private timelines can leave shareholders waiting years for an exit event, which is why some choose to explore secondary-market options.
Can you sell Vannevar Labs stock?
Whether a shareholder can sell typically depends on what they hold and how it was acquired. Vested and exercised shares are generally more straightforward than unexercised options or unvested RSUs. Most private companies, including those in the Aerospace & Defense sector, impose transfer restrictions such as rights of first refusal or board approval requirements. The specific terms governing Vannevar Labs shares would be outlined in the holder's equity agreement or the company's governing documents.
What affects the value of Vannevar Labs shares?
The price a buyer is willing to pay for private shares is shaped by several factors: overall demand for the stock, the company's financial performance, broader Aerospace & Defense market conditions, and any recent private-market transaction activity. Data points such as the company's Series C round can help frame expectations, though they do not guarantee a transaction price.
What should holders check before selling
- The type of security held (common shares, preferred, options, RSUs)
- Whether the equity is fully vested and, for options, whether it has been exercised
- Any transfer restrictions, lock-up provisions, or company approval requirements
- Estimated net proceeds after applicable taxes and transaction fees
- Whether partial liquidity — selling a portion rather than the full position — may be a better fit
Tools for Vannevar Labs shareholders
Exploring equity in Vannevar Labs often raises questions about taxes, exercise timing, valuation, and exit outcomes. These tools can help you model different decisions using your own assumptions.
Latest funding round
Vannevar Labs most recently raised a Series C round . Total funding raised to date is approximately $262M.
Lead investors in this round include Founders Fund and DFJ Growth.
Founders & company background
Vannevar Labs was founded in 2019 by Brett Granberg, Nini Moorhead and is headquartered in San Francisco, CA.
Investors
Industry
Similar private companies
Frequently asked questions
- Is Vannevar Labs still a private company?
- Yes, Vannevar Labs is currently a private company.
- What is Vannevar Labs's latest funding round?
- Vannevar Labs's most recent known round is Series C.
- What is Vannevar Labs's valuation?
- Vannevar Labs's valuation has not been publicly disclosed.
- Who are the investors in Vannevar Labs?
- Notable investors include Founders Fund, DFJ Growth.
- Can I sell my Vannevar Labs stock?
- Private company shares can sometimes be sold on secondary markets. Speaking with a specialist who understands Vannevar Labs stock can help you evaluate your options.
Related pages
Last verified: 2026-04-13 · Vannevar Labs data compiled from funding disclosures, investor announcements, corporate filings, and public records.
Information on this page is compiled from publicly available sources and may be outdated or incomplete. This is not investment advice. Consult a qualified advisor before making financial decisions.